[O8] Oral Session 8　呼吸器2（免疫チェックポイント阻害薬）
【E】

[O8-6] KEYNOTE-A17: First-Line Pembrolizumab Plus Cisplatin and Pemetrexed in Advanced Malignant Pleural Mesothelioma in Japan

^○Takashi Kijima¹, Terufumi Kato², Yasushi Goto³, Takashi Yokoi¹, Kozo Kuribayashi¹, Koji Mikami¹, Yasuko Fuchimoto⁴, Shuji Murakami², Tatsuya Yoshida³, Masae Homma⁵, Akira Wakana⁵, Kazuo Noguchi⁵, Nobukazu Fujimoto⁶ (1.Department of Respiratory Medicine and Hematology, Hyogo College of Medicine, 2.Department of Thoracic Oncology, Kanagawa Cancer Center, 3.Department of Thoracic Oncology, National Cancer Center Hospital, 4.Department of Respiratory Medicine, Okayama Rosai Hospital, 5.MSD K.K., Tokyo, Japan, 6.Department of Medical Oncology, Okayama Rosai Hospital)